Marker Therapeutics Reports MT-401 Non-Clinical Data in AML
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of the Development of MT-401 for the Treatment of AML Patients ...
Source: globenewswire.com
Stay updated with breaking news from Lauras Angelo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of the Development of MT-401 for the Treatment of AML Patients ...